• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

IPET 2015

Tuesday, 6 October 2015

International Conference on Clinical PET-CT and Molecular Imaging (IPET 2015)

International Conference on Clinical PET-CT and Molecular Imaging (IPET 2015): PET-CT in the era of multimodality imaging and image-guided therapy

Please note that only presentations that have been approved for sharing by their originators are available online.

Plenary Session IV

Hybrid Imaging and Other Imaging Techniques in Paediatrics

09.00 – 09.30

The Role of PET/CT Imaging in the Management of Paediatric Cancers Robert Howman-Giles, Australia

09.30 – 10.00

Other Imaging Modalities in Paediatric Cancers Helen Nadel, Canada

10.00 – 10.30

Dose Optimization in Paediatric Patients Madan Rehani, USA

10.30 – 11.00

Read with the Expert: PET/CT, Paediatric Cancers Robert Howman-Giles, Australia

11.00 – 11.20

Coffee Break, Poster and Exhibits Viewing

Plenary Session V

Ethics, Leadership, Education and Regulatory Issues

11.20 – 11.40

Ethical Issues in Diagnostic Imaging Practice Sobhan Vinjamuri, BNMS, UK

11.40 – 12.00

Leadership Initiatives in Nuclear Medicine Practice Akram Al-Ibraheem, ARSNM

12.00 – 12.20

Understanding How Learners Learn: Writing Learning Objectives for Educational Activities Thomas Pascual, IAEA

12.20 – 12.35

Importance of CME Credits in the Lifelong Learning Process  Teresio Varetto, Italy

12.35 – 13.00

US Production of PET Drugs for Clinical and Research Uses  Sally Schwarz, SNMMI

Parallel Session 1a

14.00 – 14.40

PET/CT Imaging in Gastrointestinal Cancers Stefano Fanti, EANM

14.40 – 15.20

Other Imaging Modalities in Gastrointestinal Cancers Gabriele Masselli, ESR

15.20 – 16.00

Read with the Expert: PET/CT, Gastrointestinal Cancers Jean Luc Urbain, CANM, Canada

Parallel Session 1b

14.00 – 14.30

PET Radiopharmaceuticals Beyond FDG Jason S. Lewis, WMIS

14.30 – 15.00

64 Radiopharmaceuticals Production and Quality Control Paola Panichelli, Italy

15.00 – 15.30

Ga 68 - Radiopharmaceuticals: Current Status and Future Frank Roesch, Germany

15.30 – 16.00

Manufacturing Regulations for Imaging Radiopharmaceuticals in the United States Orhan Suleiman, USA

Parallel Session 1c

14.00 – 14.30

Need of Tracking of Patient Doses in Nuclear Medicine and Hybrid Imaging Madan Rehani, USA

14.30 – 14.50

IAEA Activities on Radiation Protection in Diagnostic Imaging Jenia Vassileva, IAEA

14.50 – 15.15

QA/QC in PET: Accreditation, Daily QC and More Ivo Rausch, Austria

15.15 – 15.40

Advances of Detector Technology in Nuclear Medicine Satchithanantham Somanesan, SGH, Singapore

15.40 – 16.00

A Consideration of the Barriers and Potential of Data-Driven PET Innovation Adam Kesner, WFNMB

Poster Review Session II

16.00 – 17.00

Meet-the-Authors: Poster Review Thomas Pascual, IAEA

Reviewers:

  • Robert Howman-Giles, Australia
  • Teresio Varetto, Italy
  • Mohamad Haidar, Lebanon
  • Stefano Fanti, EANM
  • Jean Luc Urbain, CANM, Canada
  • Rathan Subramaniam, ACNM, USA
  • Marc Seltzer, USA
  • Batool Al-Balooshi, ARSNM
  • Francesco Giammarile, France

Plenary Session VI

17.00 – 17.20

Optimization of Clinical Protocols Kunthi Pathmaraj, WFNMB

17.20 – 17.40

Status of Mo-99 Supply and New Developments Joao A. Osso, IAEA

17.40 – 18.00

Supply of Medical Radioisotopes Kevin Charlton, Nuclear Development Division, OECD/NEA

Stay in touch

Newsletter